Cristal Therapeutics hires chief business officer from Merck
April 23, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cristal Therapeutics, Jeroen Tonnaer, Merck
Jeroen Tonnaer has been named as the new chief business officer responsible for Cristal Therapeutics’ business development, partnering and licensing …
Study reveals true scale of falsified medicines problem
April 22, 2015Manufacturing and Production, Sales and Marketing Counterfeiting, fake, falsified medicines, health, pharma, supply chain
The full scope and prevalence of counterfeit medicines is poorly understood, according to a study of global pharma supply chains. …
Amgen files high earnings for Q1
April 22, 2015Sales and Marketing AMG 334, Amgen, Corlanor, Kyprolis, Prolia, Q1, Xgeva, brodalumab, myeloma, osteoporosis
Amgen has boosted its first quarter profit by 51% due to surging drug sales and ongoing cuts that paved the …
Teva faces $512m fine in generic Provigil row
April 22, 2015Sales and Marketing Cephalon, Mylan, Teva, generic, modafinil, provigil
Teva has agreed to a record $512 million settlement in a ‘pay-to-delay’ row over generic versions of its drug Provigil. …
Two oncology successes for Pfizer
April 22, 2015Research and Development, Sales and Marketing Cancer, FDA, Inotuzumab ozogamicin, NSCLC, Pfizer, Xalkori, oncology
Pfizer has received two boosts in oncology as Xalkori gets a new breakthrough therapy designation from the FDA, and its …
Boehringer Ingelheim and Bayer ‘taking the lead’ in social media
April 22, 2015Medical Communications, Sales and Marketing Bayer, Boehringer Ingelheim, J&J and Merck, Novartis, Ogilvy Healthworld
Pharma may be finally embracing social media as a vehicle for engaging with doctors and patients, after posting more than …
EUSA Pharma appoints chief executive and director
April 22, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley
Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) …
Teva moves to buy Mylan
April 21, 2015Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger
Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
Merck KGaA and Pfizer alliance begins lung cancer study
April 21, 2015Research and Development, Sales and Marketing Merck KGaA, Pfizer, avelumab, keytruda, oncology, opdivo
Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …
Daiichi Sankyo to sell Sun Pharma stake
April 21, 2015Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics
Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …
Novartis MS drug scores positive late-stage trial result
April 21, 2015Research and Development, Sales and Marketing MS, Novartis, fingolimod, gilenya, multiple sclerosis
People with some of the most common forms of multiple sclerosis (MS) who are treated with Gilenya are less likely …
UK firm unveils respiratory apps
April 21, 2015Medical Communications, Sales and Marketing Activ8rlives, Aseptika, SENSOR, communications, digital
Cambridgeshire-based healthcare tech firm Aseptika has made its suite of apps available to support studies in respiratory research. The UK …
Four join the ranks of IDEA Pharma
April 21, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anastasia Liapis, Cindy Peché, IDEA Pharma, Louise Ward, Vivian Huang
IDEA Pharma has made four new appointments in Louise Ward as project manager and Cindy Peché as head of group …
Sanofi sues decision aid maker for ‘injurious falsehood’
April 20, 2015Medical Communications, Sales and Marketing Diagnosia, Sanofi, metamizole, tech
A tech start-up says it is being sued by pharma giant Sanofi for presenting facts about a drug’s side effects …
Merck seeks new Keytruda indication in US
April 20, 2015Sales and Marketing Cancer, FDA, NSCLC, PD-L1, US, keytruda, lung, pembrolizumab
Merck is seeking FDA approval for its successful melanoma drug Keytruda to be used treating lung cancer. The Supplemental Biologics …
Round one to Pfizer in Zoloft lawsuit battle
April 20, 2015Sales and Marketing Pfizer, Zoloft, antidepressant, birth defects, law suits, legal, sertraline
Pfizer’s Zoloft did not cause a young boy’s birth defects, a jury has ruled, in the first of a thousand …
AstraZeneca lung drug shows promise
April 20, 2015Sales and Marketing AZ, AZD9291, AstraZeneca, European Lung Cancer Congress, NSCLC, Orphan
AstraZeneca’s non-small cell lung cancer offering AZD9291 has been shown to delay disease progression by over a year. Data presented …
What you need to know about the EU Clinical Trial Regulation
April 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EU Clinical Trial Regulation, EU-CTR, Virginia Acha
Where did the EU Clinical Trial Regulation come from? The EU Clinical Trial Regulation (EU-CTR) was approved in April 2014 …
Celgene appoints former Cubist chief executive
April 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, cubist, michael bonney
Celgene has elected pharma veteran Michael Bonney to join its board of directors. Bonney served as chief executive and board …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
